Kirsa Skov‐Jeppesen

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

Christoffer Hagemann, Malene S. Jensen, Stephanie Holm et al. · Cell Reports Medicine · 2022 · 76 citations · Full text

Life Sciences, Endocrinology, Nutritional Sciences +17

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men

Kirsa Skov‐Jeppesen, Maria S. Svane, Christoffer Martinussen et al. · Bone · 2019 · 71 citations

Medicine, Endocrinology, Bone Metabolism +11

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment

M Gabe, Kirsa Skov‐Jeppesen, Lærke S. Gasbjerg et al. · Pharmacological Research · 2022 · 43 citations

Medicine, Endocrinology, Pharmacotherapy +16

Effects of endogenous GIP in patients with type 2 diabetes

Signe Stensen, Lærke S. Gasbjerg, L. L. Krogh et al. · European Journal of Endocrinology · 2021 · 41 citations · Full text

Medicine, Endocrinology, Pharmacology +11

A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans

Anne Nissen, Simone Diedrichsen Marstrand, Kirsa Skov‐Jeppesen et al. · JBMR Plus · 2019 · 34 citations · Full text

Medicine, Endocrinology, Pharmacology +17